YY001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for YY001, covering 2025-01-03 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity [Phase 3]